| Biological Information | |
|---|---|
| Background Information: | CDK18, cyclin dependent kinase 18, is predicted to enable ATP binding activity and to be involved in protein phosphorylation and regulation of transcription involved in G1/S transition of mitotic cell cycle. It may play a role in signal transduction cascades in terminally differentiated cells. [provided by Alliance of Genome Resources, Apr 2022] |
| Target Class: | Kinase |
| Family: | Serine/Threonine Kinase: TAIRE subfamily |
| Accession Number: | NM_212502.1. The recombinant protein contains one residue which is in conflict with NM_212502.1. This is T166M and is reported in GenBank BC011526.1. |
| Target Name: | CDK18 |
| Target Aliases: | Cyclin Dependent Kinase 18, PCTAIRE3, PCTK3, Serine/Threonine-Protein Kinase PCTAIRE-3, PCTAIRE Protein Kinase 3 |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 1 year at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
CDK18/cyclin Y, active
active CDK18/cyclin Y. N-terminal GST-tagged, recombinant, human CDK18 full length and N-terminal GST-tagged, recombinant human cyclin Y full length.
Datasheets
15-031x Datasheet
View Document